259 related articles for article (PubMed ID: 33046156)
21. Treating mixed mania/hypomania: a review and synthesis of the evidence.
Takeshima M
CNS Spectr; 2017 Apr; 22(2):177-185. PubMed ID: 28004626
[TBL] [Abstract][Full Text] [Related]
22. Risperidone long-acting injectable monotherapy in the maintenance treatment of bipolar I disorder.
Quiroz JA; Yatham LN; Palumbo JM; Karcher K; Kushner S; Kusumakar V
Biol Psychiatry; 2010 Jul; 68(2):156-62. PubMed ID: 20227682
[TBL] [Abstract][Full Text] [Related]
23. Lithium for acute mania.
McKnight RF; de La Motte de Broöns de Vauvert SJGN; Chesney E; Amit BH; Geddes J; Cipriani A
Cochrane Database Syst Rev; 2019 Jun; 6(6):CD004048. PubMed ID: 31152444
[TBL] [Abstract][Full Text] [Related]
24. Continuation of quetiapine versus switching to placebo or lithium for maintenance treatment of bipolar I disorder (Trial 144: a randomized controlled study).
Weisler RH; Nolen WA; Neijber A; Hellqvist A; Paulsson B;
J Clin Psychiatry; 2011 Nov; 72(11):1452-64. PubMed ID: 22054050
[TBL] [Abstract][Full Text] [Related]
25. Olanzapine in long-term treatment for bipolar disorder.
Cipriani A; Rendell JM; Geddes J
Cochrane Database Syst Rev; 2009 Jan; (1):CD004367. PubMed ID: 19160237
[TBL] [Abstract][Full Text] [Related]
26. Differential efficacy of olanzapine and lithium in preventing manic or mixed recurrence in patients with bipolar I disorder based on number of previous manic or mixed episodes.
Ketter TA; Houston JP; Adams DH; Risser RC; Meyers AL; Williamson DJ; Tohen M
J Clin Psychiatry; 2006 Jan; 67(1):95-101. PubMed ID: 16426094
[TBL] [Abstract][Full Text] [Related]
27. Long-Acting Injectable Second-Generation/Atypical Antipsychotics for the Management of Bipolar Disorder: A Systematic Review.
Keramatian K; Chakrabarty T; Yatham LN
CNS Drugs; 2019 May; 33(5):431-456. PubMed ID: 30963507
[TBL] [Abstract][Full Text] [Related]
28. A systematic review and economic model of the clinical effectiveness and cost-effectiveness of interventions for preventing relapse in people with bipolar disorder.
Soares-Weiser K; Bravo Vergel Y; Beynon S; Dunn G; Barbieri M; Duffy S; Geddes J; Gilbody S; Palmer S; Woolacott N
Health Technol Assess; 2007 Oct; 11(39):iii-iv, ix-206. PubMed ID: 17903393
[TBL] [Abstract][Full Text] [Related]
29. [Treatment of manic phases of bipolar disorder: critical synthesis of international guidelines].
Geoffroy PA; Bellivier F; Henry C
Encephale; 2014 Sep; 40(4):330-7. PubMed ID: 24513018
[TBL] [Abstract][Full Text] [Related]
30. A randomized, placebo-controlled 12-month trial of divalproex and lithium in treatment of outpatients with bipolar I disorder. Divalproex Maintenance Study Group.
Bowden CL; Calabrese JR; McElroy SL; Gyulai L; Wassef A; Petty F; Pope HG; Chou JC; Keck PE; Rhodes LJ; Swann AC; Hirschfeld RM; Wozniak PJ
Arch Gen Psychiatry; 2000 May; 57(5):481-9. PubMed ID: 10807488
[TBL] [Abstract][Full Text] [Related]
31. Olanzapine is superior to lamotrigine in the prevention of bipolar depression: a naturalistic observational study.
Pan PY; Lee MS; Lo MC; Yang EL; Yeh CB
BMC Psychiatry; 2014 May; 14():145. PubMed ID: 24885966
[TBL] [Abstract][Full Text] [Related]
32. Optimal duration of risperidone or olanzapine adjunctive therapy to mood stabilizer following remission of a manic episode: A CANMAT randomized double-blind trial.
Yatham LN; Beaulieu S; Schaffer A; Kauer-Sant'Anna M; Kapczinski F; Lafer B; Sharma V; Parikh SV; Daigneault A; Qian H; Bond DJ; Silverstone PH; Walji N; Milev R; Baruch P; da Cunha A; Quevedo J; Dias R; Kunz M; Young LT; Lam RW; Wong H
Mol Psychiatry; 2016 Aug; 21(8):1050-6. PubMed ID: 26460229
[TBL] [Abstract][Full Text] [Related]
33. Randomized, Double-Blind, Placebo-Controlled Trial of Asenapine Maintenance Therapy in Adults With an Acute Manic or Mixed Episode Associated With Bipolar I Disorder.
Szegedi A; Durgam S; Mackle M; Yu SY; Wu X; Mathews M; Landbloom RP
Am J Psychiatry; 2018 Jan; 175(1):71-79. PubMed ID: 28946761
[TBL] [Abstract][Full Text] [Related]
34. Cost effectiveness of adjunctive quetiapine fumarate extended-release tablets with mood stabilizers in the maintenance treatment of bipolar I disorder.
Woodward TC; Tafesse E; Quon P; Lazarus A
Pharmacoeconomics; 2010; 28(9):751-64. PubMed ID: 20623994
[TBL] [Abstract][Full Text] [Related]
35. A randomized, placebo- and active-controlled study of paliperidone extended-release as maintenance treatment in patients with bipolar I disorder after an acute manic or mixed episode.
Berwaerts J; Melkote R; Nuamah I; Lim P
J Affect Disord; 2012 May; 138(3):247-58. PubMed ID: 22377512
[TBL] [Abstract][Full Text] [Related]
36. Effectiveness of psychotropic medications in the maintenance phase of bipolar disorder: a meta-analysis of randomized controlled trials.
Vieta E; Günther O; Locklear J; Ekman M; Miltenburger C; Chatterton ML; Åström M; Paulsson B
Int J Neuropsychopharmacol; 2011 Sep; 14(8):1029-49. PubMed ID: 21733231
[TBL] [Abstract][Full Text] [Related]
37. Real-world effectiveness of long-acting injectable vs. oral antipsychotics in patients with bipolar I disorder: a 1-year retrospective observational study.
Korkmaz ŞA; Gürler S
Curr Med Res Opin; 2024 May; 40(5):855-861. PubMed ID: 38557295
[TBL] [Abstract][Full Text] [Related]
38. Aripiprazole for the maintenance treatment of bipolar I disorder: A review.
McIntyre RS
Clin Ther; 2010; 32 Suppl 1():S32-8. PubMed ID: 20152551
[TBL] [Abstract][Full Text] [Related]
39. Efficacy and safety of long-term antidepressant treatment for bipolar disorders - A meta-analysis of randomized controlled trials.
Liu B; Zhang Y; Fang H; Liu J; Liu T; Li L
J Affect Disord; 2017 Dec; 223():41-48. PubMed ID: 28715727
[TBL] [Abstract][Full Text] [Related]
40. Standard versus reduced dose of antipsychotics for relapse prevention in multi-episode schizophrenia: a systematic review and meta-analysis of randomised controlled trials.
Højlund M; Kemp AF; Haddad PM; Neill JC; Correll CU
Lancet Psychiatry; 2021 Jun; 8(6):471-486. PubMed ID: 34023019
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
